More than A$130 billion spent on health in Australia in 2010-11

26 September 2012

According to a report released this week by the Australian Institute of Health and Welfare (AIHW) spending on health was estimated at about $130.3 billion ($136 billion) in 2010-11, up from $122.5 billion in 2009-10 (after adjusting for inflation). The largest component of the increase in Australian expenditure in 2010-11 was an A$2.2 billion rise in spending on public hospitals, followed by spending on medications, which grew by A$2.1 billion.

“While total health expenditure has risen, health expenditure as a proportion of Australia's gross domestic product (GDP) dropped slightly compared to the previous year,” said AIHW director and chief executive David Kalisch. In 2010-11, health expenditure as a percentage of GDP was 9.3%, compared to 9.4% in 2009-10, the report revealed.

“In recent years, the ratio of health expenditure to GDP has risen-however this was largely the result of a slowing in GDP growth following the global financial crisis, rather than extraordinary health expenditure growth. This situation now appears to have stabilised somewhat,” Mr Kalisch said.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight



More Features in Pharmaceutical